3 Simple Reasons I like TG Therapeutics Inc (NASDAQ:TGTX) Stock Long-Term

TG Therapeutics Inc (NASDAQ:TGTX) is an AbbVie (NYSE:ABBV) or Johnson & Johnson (NYSE:JNJ) buyout waiting to happen, good news for TGTX stock owners.

Posted in Editor's Pick, Healthcare & Biotech, Members, Mergers & Acquisitions | Tagged , , , , , | 1 Comment

Why TG Therapeutics Inc (NASDAQ:TGTX) Stock Is Just Getting Warmed Up

TG Therapeutics Inc (NASDAQ:TGTX) is still cheap; has inevitable commercial success; and TGTX stock has AbbVie (NYSE:ABBV) buyout all over it.

Posted in Healthcare & Biotech, Members, Mergers & Acquisitions | Tagged , , , , | 2 Comments

Why Acadia Pharmaceuticals (ACAD) Will Get More Than $44 From Pfizer (PFE)

Why ACAD stock will be the next Medivation. Pfizer, Gilead, Teva, Bristol-Myers, Otsuka & AbbVie are all companies that would want Nuplazid & Acadia Pharma

Posted in Healthcare & Biotech, Members, Mergers & Acquisitions | Tagged , , , , , , , , | 1 Comment

Why ACADIA Pharmaceuticals Inc (ACAD) Stock Loss Will Reverse With Nuplazid Sales, Eventually!

Can’t sell ACAD stock just because third quarter Nuplazid sales are likely poor. Not when Gilead (GILD), Pfizer (PFE), Biogen Idec (BIIB) and many others are likely suitors.

Posted in Healthcare & Biotech, Mergers & Acquisitions | Tagged , , , , , , , , , | 1 Comment